Zapnometinib

N/A

Report date: 2022/09/28 20:01:03
NME

Base Information

Drug NameZapnometinib
Drug Alias NameATR-002PD-0184264
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumPolandRomania +[8] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital Muenster
China Registration ClassN/A

Develop Information

Active CompaniesAtriva Therapeutics Gmbh
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human

Other Information

ATC CodeN/A
Related LinksN/A